Skip to content

Clinical trials

Completed Phase 1 Leukemia, B-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, B-Cell Phase: Phase 1 Status: Completed Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20072
20082
20093
20102
20111
20125
20132
20141
20181
20191
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memgen, LLC3
Celgene2
National Cancer Institute (NCI)2
Pharmacyclics LLC.2
AbbVie1
AstraZeneca1
Cancer Research UK1
Celgene Corporation1
Gilead Sciences1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, B-Cell25
Leukemia, Lymphocytic, Chronic, B-Cell14
Lymphoma, B-Cell8
Lymphoma, Non-Hodgkin8
Leukemia7
Lymphoma5
Multiple Myeloma4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Waldenstrom Macroglobulinemia4
Burkitt Lymphoma3

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.